The tumor microenvironment has been implicated in the failure of immune surveillance and the limited efficacy of immune based therapies due to the decreased oxygen availability (hypoxia) and accumulation of adenosine that occur in solid tumors. Both hypoxia and adenosine strongly inhibit the function of tumor infiltrating lymphocytes (TIL) limiting their ability to drive tumor elimination. The functionality of T lymphocytes relies on ion channels that control Ca2+ influx which is essential for the activation and function of these immune cells. Specifically two potassium channels, Kv1.3 and KCa3.1, play critical roles by regulating the driving force for Ca2+ influx through Ca2+ channels. Over the years we have investigated the effects of hypoxia and adenosine on ion channels in circulating T lymphocytes from healthy individuals. We have shown that hypoxia suppresses T cell proliferation and cytokine release via Kv1.3. Furthermore, adenosine inhibits the motility of cells via selective inhibition of KCa3.1. The mechanisms that link adenosine's inhibition of KCa3.1 to reduced T cell motility are not understood. Moreover, no information is available as to whether alterations in Kv1.3 and KCa3.1 are present in TILs from cancer patients. Therefore, in the current application we will test the hypothesis that inhibition of potassium channels in T lymphocytes by the tumor microenvironment contributes to the failure of the immune system to invade the tumor mass and fight cancer cells. We will perform experiments to identify the ionic mechanisms by which adenosine suppresses T cell motility. Furthermore, we will study whether the down regulation of ion channels in TILs by the tumor microenvironment contributes to their inability to develop the appropriate Ca2+ responses necessary for motility and effector functions. Findings from the proposed studies will provide new insights into the mechanisms involved in decrease immune surveillance in solid tumors. Such data are critical to develop new therapies aimed to reduce tumor immune escape.

Public Health Relevance

One of the functions of the immune system is to attack cancer cells and destroy them. Unfortunately there are special conditions in tumors that inhibit immune cell ability to do this. We propose to study how the effects of those conditions on ion channels in the membrane of immune cells contribute to the failure of the immune system to fight cancer cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA095286-11
Application #
9102972
Study Section
Cellular and Molecular Immunology - A Study Section (CMIA)
Program Officer
Mccarthy, Susan A
Project Start
2002-04-01
Project End
2020-06-30
Budget Start
2016-07-01
Budget End
2017-06-30
Support Year
11
Fiscal Year
2016
Total Cost
Indirect Cost
Name
University of Cincinnati
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041064767
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Chimote, Ameet A; Balajthy, Andras; Arnold, Michael J et al. (2018) A defect in KCa3.1 channel activity limits the ability of CD8+ T cells from cancer patients to infiltrate an adenosine-rich microenvironment. Sci Signal 11:
Chimote, Ameet A; Hajdu, Peter; Sfyris, Alexandros M et al. (2017) Kv1.3 Channels Mark Functionally Competent CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Cancer. Cancer Res 77:53-61
Conforti, Laura (2017) Potassium channels of T lymphocytes take center stage in the fight against cancer. J Immunother Cancer 5:2
Chimote, Ameet A; Hajdu, Peter; Kottyan, Leah C et al. (2016) Nanovesicle-targeted Kv1.3 knockdown in memory T cells suppresses CD40L expression and memory phenotype. J Autoimmun 69:86-93
Hajdu, Peter; Martin, Geoffrey V; Chimote, Ameet A et al. (2015) The C-terminus SH3-binding domain of Kv1.3 is required for the actin-mediated immobilization of the channel via cortactin. Mol Biol Cell 26:1640-51
Hajdu, Péter; Chimote, Ameet A; Thompson, Tyler H et al. (2013) Functionalized liposomes loaded with siRNAs targeting ion channels in effector memory T cells as a potential therapy for autoimmunity. Biomaterials 34:10249-57
Chimote, Ameet A; Hajdu, Peter; Kucher, Vladimir et al. (2013) Selective inhibition of KCa3.1 channels mediates adenosine regulation of the motility of human T cells. J Immunol 191:6273-80
Kuras, Zerrin; Kucher, Vladimir; Gordon, Scott M et al. (2012) Modulation of Kv1.3 channels by protein kinase A I in T lymphocytes is mediated by the disc large 1-tyrosine kinase Lck complex. Am J Physiol Cell Physiol 302:C1504-12
Conforti, Laura (2012) The ion channel network in T lymphocytes, a target for immunotherapy. Clin Immunol 142:105-6
Martin, Geoffrey V; Yun, Yeoheung; Conforti, Laura (2012) Modulation of T cell activation by localized Kýýý accumulation at the immunological synapse--a mathematical model. J Theor Biol 300:173-82

Showing the most recent 10 out of 22 publications